Literature DB >> 26320890

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Carolyn H Still1, Timothy E Craven2, Barry I Freedman3, Peter N Van Buren4, Kaycee M Sink5, Anthony A Killeen6, Jeffrey T Bates7, Alberta Bee8, Gabriel Contreras9, Suzanne Oparil10, Carolyn M Pedley11, Barry M Wall12, Suzanne White13, Delia M Woods14, Carlos J Rodriguez15, Jackson T Wright16.   

Abstract

The Systolic Blood Pressure Intervention Trial (SPRINT) will compare treatment to a systolic blood pressure goal of <120 mm Hg to treatment to the currently recommended goal of <140 mm Hg for effects on incident cardiovascular, renal, and neurologic outcomes including cognitive decline. The objectives of this analysis are to compare baseline characteristics of African American (AA) and non-AA SPRINT participants and explore factors associated with uncontrolled blood pressure (BP) by race. SPRINT enrolled 9361 hypertensive participants aged older than 50 years. This cross-sectional analysis examines sociodemographics, baseline characteristics, and study measures among AAs compared with non-AAs. AAs made up 31% of participants. AAs (compared with non-AAs) were younger and less frequently male, had less education, and were more likely uninsured or covered by Medicaid. In addition, AAs scored lower on the cognitive screening test when compared with non-AAs. Multivariate logistic regression analysis found BP control rates to <140/90 mm Hg were higher for AAs who were male, had higher number of chronic diseases, were on diuretic treatment, and had better medication adherence. SPRINT is well poised to examine the effects of systolic blood pressure targets on clinical outcomes as well as predictors influencing BP control in AAs.
Copyright © 2015 American Society of Hypertension. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; SPRINT; blacks; clinical trials; hypertension

Mesh:

Substances:

Year:  2015        PMID: 26320890      PMCID: PMC4573272          DOI: 10.1016/j.jash.2015.06.012

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  27 in total

1.  Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.

Authors:  John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Authors:  Carolyn H Still; Keith C Ferdinand; Gbenga Ogedegbe; Jackson T Wright
Journal:  J Am Geriatr Soc       Date:  2015-10       Impact factor: 5.562

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

4.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

5.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

6.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.

Authors:  Wilbert S Aronow; Jerome L Fleg; Carl J Pepine; Nancy T Artinian; George Bakris; Alan S Brown; Keith C Ferdinand; Mary Ann Forciea; William H Frishman; Cheryl Jaigobin; John B Kostis; Giuseppi Mancia; Suzanne Oparil; Eduardo Ortiz; Efrain Reisin; Michael W Rich; Douglas D Schocken; Michael A Weber; Deborah J Wesley
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

9.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

10.  Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction.

Authors:  S Madhavan; W L Ooi; H Cohen; M H Alderman
Journal:  Hypertension       Date:  1994-03       Impact factor: 10.190

View more
  7 in total

1.  SPRINT and Implications for Target Organ Protection in African Americans.

Authors:  Jackson T Jr Wright; Lawrence J Fine
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

Review 2.  Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines.

Authors:  Stephen K Williams; Joseph Ravenell; Sara Seyedali; Sam Nayef; Gbenga Ogedegbe
Journal:  Prog Cardiovasc Dis       Date:  2016-09-29       Impact factor: 8.194

3.  Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.

Authors:  Kathleen Dungan; Timothy E Craven; Kyaw Soe; Jackson T Wright; Jan Basile; William E Haley; Nancy R Kressin; Uzma Rani; Leonardo Tamariz; Jeff Whittle; Alan Wiggers; Kwame Osei
Journal:  Diabetes Obes Metab       Date:  2017-11-09       Impact factor: 6.577

4.  Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial.

Authors:  Carlos J Rodriguez; Carolyn H Still; Katelyn R Garcia; Lynne Wagenknecht; Suzanne White; Jeffrey T Bates; Margareth V Del Cid; Michael Lioudis; Nieves Lopez Barrera; Abel Moreyra; Henry Punzi; Robert J Ringer; William C Cushman; Gabriel Contreras; Karen Servilla; Michael Rocco
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-14       Impact factor: 3.738

5.  Oscillometric blood pressure by age and height for non overweight children and adolescents in Lubumbashi, Democratic Republic of Congo.

Authors:  Emmanuel Kiyana Muyumba; Dophra Ngoy Nkulu; Clarence Kaut Mukeng; Jacques Mbaz Musung; Placide Kambola Kakoma; Christian Ngama Kakisingi; Oscar Numbi Luboya; Françoise Kaj Malonga; Justin Kalungwe Kizonde; Olivier Mukuku; Weili Yan
Journal:  BMC Cardiovasc Disord       Date:  2018-01-19       Impact factor: 2.298

6.  Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.

Authors:  Carolyn H Still; Carlos J Rodriguez; Jackson T Wright; Timothy E Craven; Adam P Bress; Glenn M Chertow; Paul K Whelton; Jeffrey C Whittle; Barry I Freedman; Karen C Johnson; Capri G Foy; Jiang He; John B Kostis; James P Lash; Carolyn F Pedley; Roberto Pisoni; James R Powell; Barry M Wall
Journal:  Am J Hypertens       Date:  2017-12-08       Impact factor: 2.689

7.  Implementation of Outpatient Pharmacist-led Hypertension Management for Under-Resourced Patients: A Pilot Study.

Authors:  Brittany Stewart; Aaron Brody; Candice L Garwood; Liying Zhang; Phillip D Levy
Journal:  Innov Pharm       Date:  2021-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.